Development of chemiluminescence method based on serum type I collagen hydroxyl terminal peptide β special sequence (β-CTX)

References

• Filardi T, Carnevale V, Massoud R, et al. High serum osteopontin levels are associated with prevalent fractures and worse lipid profile in post-menopausal women with type 2 diabetes. J Endocrinol Invest. 2019;42(3):295–301.
   PubMed Web of Science ®Google Scholar
• El Deeb S, Abdelnaby R, Khachab A, et al. Osteopontin as a biochemical marker and severity indicator for idiopathic hip osteoarthritis. Hip Int. 2016;26(4):397–403.
   PubMed Web of Science ®Google Scholar
• Gulin T, Kruljac I, Kirigin L, et al. Advanced age, high beta-CTX levels, and impaired renal function are independent risk factors for all-cause 1-year mortality in hip fracture patients. Calcif Tissue Int. 2016;98(1):67–75.
   PubMed Web of Science ®Google Scholar
• Green C, Molony D, Fitzpatrick C, et al. Age-specific incidence of hip fracture in the elderly: a healthy decline. Surgeon. 2010;8(6):310–313.
   PubMed Web of Science ®Google Scholar
• Curry SJ, Krist AH, Owens DK, et al. Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement. JAMA. 2018;319(24):2521–2531.
   PubMed Web of Science ®Google Scholar
• Li NN, Cornelissen D, Silverman S, et al. An updated systematic review of cost-effectiveness analyses of drugs for osteoporosis. Pharmacoeconomics. 2021;39(2):181–209.
   PubMed Web of Science ®Google Scholar
• Gossiel F, Altaher H, Reid DM, et al. Bone turnover markers after the menopause: T-score approach. Bone. 2018;111:44–48.
   PubMed Web of Science ®Google Scholar
• Dhiman P, Andersen S, Vestergaard P, et al. Does bone mineral density improve the predictive accuracy of fracture risk assessment? A prospective cohort study in northern Denmark. BMJ Open. 2018;8(4):e18898.
   PubMed Web of Science ®Google Scholar
• Hojsager FD, Rand MS, Pedersen SB, et al. Fracture-induced changes in biomarkers CTX, PINP, OC, and BAP-a systematic review. Osteoporos Int. 2019;30(12):2381–2389.
   PubMed Web of Science ®Google Scholar
• Balto KA, Gomaa MM, Feteih RM, et al. Dental panoramic radiographic indices as a predictor of osteoporosis in postmenopausal Saudi women. J Bone Metab. 2018;25(3):165–173.
   PubMedGoogle Scholar
• Szulc P, Naylor K, Hoyle NR, et al. Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability. Osteoporos Int. 2017;28(9):2541–2556.
   PubMed Web of Science ®Google Scholar
• Naylor KE, Mccloskey EV, Jacques RM, et al. Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis. Osteoporos Int. 2019;30(4):917–922.
   PubMed Web of Science ®Google Scholar
• Okabe R, Nakatsuka K, Inaba M, et al. Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a new assay for degradation products of type I collagen C-telopeptides. Clin Chem. 2001;47(8):1410–1414.
   PubMed Web of Science ®Google Scholar
• Bernotiene E, Bagdonas E, Kirdaite G, et al. Emerging technologies and platforms for the immunodetection of multiple biochemical markers in osteoarthritis research and therapy. Front Med. 2020;7:572977.
   Web of Science ®Google Scholar
• Hu T, Yang Q, Xu J, et al. Role of beta-isomerized C-terminal telopeptides (beta-CTx) and total procollagen type 1 amino‐terminal propeptide (tP1NP) as osteosarcoma biomarkers. Int J Clin Exp Med. 2015;8(1):890–896.
   PubMed Web of Science ®Google Scholar
• Rossi L, Copes RM, Dal Osto LC, et al. Factors related with osteoporosis treatment in postmenopausal women. Medicine. 2018;97(28):e11524.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Cooper C, Rizzoli R, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30(1):3–44.
   PubMed Web of Science ®Google Scholar
• Vasikaran S, Eastell R, Bruyere O, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22(2):391–420.
   PubMed Web of Science ®Google Scholar
• McCloskey E, Rathi J, Heijmans S, et al. The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study. Osteoporos Int. 2021;32(2):251–259.
   PubMed Web of Science ®Google Scholar
• Yang S, Liu Y, Shi Q, et al. Characteristics of bone biochemical indices in predicting secondary osteoporotic fracture after intertrochanteric fracture in elderly women. J Orthop Translat. 2018;12:1–5.
   PubMed Web of Science ®Google Scholar
• Pietrzyk B, Wyskida K, Ficek J, et al. Relationship between plasma levels of sclerostin, calcium–phosphate disturbances, established markers of bone turnover, and inflammation in haemodialysis patients. Int Urol Nephrol. 2019;51(3):519–526.
   PubMed Web of Science ®Google Scholar
• Al-Yatama FI, AlOtaibi F, Al-Bader MD, et al. The effect of clothing on vitamin D status, bone turnover markers, and bone mineral density in young Kuwaiti females. Int J Endocrinol. 2019; 2019:6794837.
   PubMed Web of Science ®Google Scholar
• Lu MD, Hollis BW, Carey VJ, et al. Determinants and measurement of neonatal vitamin D: overestimation of 25(OH)D in cord blood using CLIA assay technology. J Clin Endocrinol Metab. 2020;105(4):e1085–e1092.
   Web of Science ®Google Scholar
• Chen DM, Zhang YJ, Xu YJ, et al. Comparison of chemiluminescence immunoassay, enzyme-linked immunosorbent assay and passive agglutination for diagnosis of Mycoplasma pneumoniae infection. Ther Clin Risk Manag. 2018;14:1091–1097.
   PubMed Web of Science ®Google Scholar
• Cosman F, de Beur SJ, LeBoff MS, et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359–2381.
   PubMed Web of Science ®Google Scholar
• Yan GM, Huang YQ, HCao H, et al. Association of breastfeeding and postmenopausal osteoporosis in Chinese women: a community-based retrospective study. BMC Womens Health. 2019;19:110.
   PubMed Web of Science ®Google Scholar
• He JQ, Xu SB, Zhang BZ, et al. Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis. Aging. 2020;12(9):8583–8604.
   PubMedGoogle Scholar
• Lin JC, Liu ZG, Liu RR, et al. The increase of osteopontin and β-carboxy-terminal cross-linking telopeptide of type I collagen enhances the risk of hip fracture in the elderly. J Clin Lab Anal. 2020;34(5):e23204.
   PubMed Web of Science ®Google Scholar
• Gavala A, Makris K, Korompeli A, et al. Evaluation of bone metabolism in critically ill patients using CTx and PINP. Biomed Res Int. 2016;2016:1951707.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Zhang XF, Jiang J, et al. Postmenopausal iron overload exacerbated bone loss by promoting the degradation of type I collagen. Biomed Res Int. 2017;2017:1–9.
   Web of Science ®Google Scholar
• Gu FL, Jiang J, Wang S, et al. An experimental research into the potential therapeutic effects of anti-osteoporosis decoction and Yougui pill on ovariectomy-induced osteoporosis. Am J Transl Res. 2019;11:6032–6039.
   PubMed Web of Science ®Google Scholar